Effect of an increased clopidogrel maintenance dose or lansoprazole co-administration on the antiplatelet response to clopidogrel in CYP2C19-genotyped healthy subjects

被引：32
|
作者：
Hulot, J. -S. [1 ,2 ,3 ]
Wuerzner, G. [4 ]
Bachelot-Loza, C. [5 ]
Azizi, M. [4 ,6 ]
Blanchard, A. [4 ]
Peyrard, S. [4 ]
Funck-Brentano, C. [1 ,2 ,3 ]
Gaussem, P. [5 ,6 ,7 ]
机构：
[1] Hop La Pitie Salpetriere, AP HP, Serv Pharmacol, Unite Pharmacogenet,Ctr Invest Biomed, F-75013 Paris, France
[2] Univ Paris, UPMC, Paris, France
[3] INSERM, UMR S 956, Paris, France
[4] Hop Europeen Georges Pompidou, AP HP, Ctr Invest Clin, INSERM,CIC 9201, Paris, France
[5] INSERM, UMR S 765, Fac Pharm, Paris, France
[6] Univ Paris 05, Paris, France
[7] Hop Europeen Georges Pompidou, AP HP, Serv Hematol Biol, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2010年 / 8卷 / 03期
关键词：
OF-FUNCTION POLYMORPHISM;
D O I：
10.1111/j.1538-7836.2009.03729.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：610 / 613
页数：4
相关论文
共 5 条
  • [1] Non-antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype
    Zhang, Yin-Zhuang
    Chen, Bi-Lian
    Zhang, Wei
    Cao, Xin
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (01): : 22 - 26
  • [2] Antiplatelet response to clopidogrel is associated with a haplotype in CYP2C19 gene in Pakistani patients
    Ahmed, Sagheer
    Gul, Saima
    Siraj, Sami
    Hussain, Abrar
    Sheikh, Fahad Sultan
    Shah, Saeed Ullah
    Janjua, Kholood
    Khan, Hizbullah
    Hamdard, Mohammad Hamid
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] CYP2C19 Genetic Polymorphism, Rabeprazole and Esomeprazole Have no Effect on the Antiplatelet Action of Clopidogrel
    El-Halabi, Mustapha M.
    Zgheib, Nathalie
    Mansour, Nabil M.
    Malli, Ahmad
    Ghaith, Ola A.
    Mahfouz, Rami
    Alam, Samir
    Sharara, Ala I.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2013, 62 (01) : 41 - 49
  • [4] Isolated and interactive impact of common CYP2C19 genetic variants on the antiplatelet effect of chronic clopidogrel therapy
    Sibbing, D.
    Gebhard, D.
    Koch, W.
    Braun, S.
    Stegherr, J.
    Morath, T.
    Von Beckerath, N.
    Mehilli, J.
    Schoemig, A.
    Schuster, T.
    Kastrati, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (08) : 1685 - 1693
  • [5] Effect of high-dose clopidogrel according to CYP2C19*2 genotype in patients undergoing percutaneous coronary intervention- a systematic review and meta-analysis
    Zhang, Lanning
    Yang, Jie
    Zhu, Xiaoquan
    Wang, Xuyun
    Peng, Li
    Li, Xiaoqi
    Cheng, Peng
    Yin, Tong
    THROMBOSIS RESEARCH, 2015, 135 (03) : 449 - 458
1